Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review.

Myriam MirzaLutz GoerkeAnna AndersonTim Wilsdon

Published in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research (2024)

Current literature supports NGS's cost-effectiveness as an oncology biomarker testing strategy under specific conditions. These findings underscore the need to develop policies to support holistic assessment of NGS to ensure appropriate reimbursement and access.

Keyphrases

public health
palliative care
systematic review
healthcare
case report
mental health
copy number
dna methylation
circulating tumor
genome wide